Business architecture

One entity.
Six coordinated business units.

Eljays operates as an integrated pharmaceutical value chain — with clear mandates across pharmaceuticals, consumer health, manufacturing, distribution, retail and science.

01

Eljays Pharmaceuticals

Prescription medicines, branded generics and essential medicines.

  • Own-brand generic medicines
  • Licensed pharmaceutical products
  • Product registration and dossier ownership
  • Chronic-disease medicines
  • Hospital & institutional products
  • Technology-transfer opportunities
02

Eljays Consumer Health

OTC, complementary medicine, sports recovery, self-care and wellness.

  • Cycli Rec — founding brand
  • Sports & active-lifestyle products
  • Cough, cold & respiratory support
  • Digestive & metabolic health
  • Women's health & dermatology
  • Evidence-led natural formulations
03

Eljays Manufacturing

Progressive vertical integration — from contract manufacturing to a compliant pharmaceutical facility.

  • Phase 1 — Contract manufacturing
  • Phase 2 — Secondary packaging & assembly
  • Phase 3 — Selected internal production
  • Phase 4 — Full manufacturing platform
  • Private-label & tech transfer
  • Export-ready quality systems
04

Eljays Trade & Distribution

Wholesale, trade, logistics and institutional supply.

  • Pharmacy & clinic supply
  • Hospital & institutional supply
  • Direct manufacturer-to-provider
  • Cross-border distribution
  • Inventory & expiry management
  • Tender & procurement support
05

Eljays Pharmacy & Digital Retail

Direct access to medicines, health products and professional pharmacy services — now operating at Pharmacy at SPAR Ninapark.

  • Licensed community pharmacies
  • Pharmacy at SPAR Ninapark — now open
  • Online ordering & fulfilment
  • Prescription & chronic-medicine services
  • Nurse-led clinic & virtual care
  • OTC, self-care & sports products
  • Corporate & employer wellness
  • Ethical market-access feedback
06

Eljays Science & Product Development

Research, formulation, product evaluation and pharmaceutical intelligence.

  • Formulation & stability programmes
  • Regulatory-dossier coordination
  • Analytical-testing partnerships
  • Pharmacovigilance support
  • Indigenous-knowledge evaluation
  • Intellectual-property development
Now operating

Pharmacy at SPAR Ninapark.

The first licensed community pharmacy in Eljays' retail network — medicines, repeat scripts, nurse-led clinic care, virtual doctor consultations and free local delivery at Northdale Shopping Centre, Ninapark.

Innovation in scarcity · Tech partner

Aflu Med Healthcare.

Eljays has selected Aflu Med Healthcare as its technology and innovation partner — a healthcare infrastructure and operations company that builds and deploys the digital and operational systems behind better care delivery. Together, we make healthcare accessible, affordable, and of quality.

Innovating for scarcity

Aflu Med does not design for ideal conditions. It designs for the realities of African healthcare — scarce clinicians, unstable connectivity, and constrained budgets — and builds systems that still work there.

HealthSpace platform

One patient. One health record. A connected ecosystem across patients, providers and payers — EHR, telehealth, AI symptom tools, referrals, billing and WhatsApp-based access.

Operational outcomes

Less fragmentation, fewer duplicated efforts, faster decisions, and a stronger foundation for scale — multiplying clinical capacity rather than demanding more of it.

Healthcare made accessible, affordable, quality.

Aflu Med's HealthSpace connects people, processes and care workflows — from solo practices and group practices to hospitals, funders, occupational health, NGOs and public-health programmes across Africa.

Growth roadmap

Five phases to an African pharmaceutical platform.

Phase 1
Foundation & formalisation
Phase 2
Market entry & portfolio expansion
Phase 3
Owned pharmaceutical portfolio
Phase 4
Manufacturing scale
Phase 5
African pharmaceutical platform

Explore partnership opportunities.

Manufacturing, distribution, private label, licensing, retail collaboration or institutional supply — we're building the platform in partnership.